Preparation and evaluation of gel formulations for oral sustained delivery to dysphagic patients

References

• Hanya M, Itoh Y, Hiraiwa H, Arakawa T, Inagaki K, Okamoto Y, (1997). An in vitro study on the release of caffeine from an agar-jelly preparation for a patient with tremors. Jpn J Hosp Pharm, 23:375–80.
   Google Scholar
• Kaneuchi M, Kohri N, Senbongi K, Sakai H, Iseki K. (2005). Preparing and evaluation of oral dosage form of ketamine considering simplicity for preparation in hospital and ease for patients to take. 1. Preparations using agar. Yakugaku Zasshi, 125:187–96.
   PubMed Web of Science ®Google Scholar
• Hanawa T, Watanabe A, Hidaka M, Sugihara M, Watanabe M, Rikihisa T. (1996). New oral dosage form for elderly patients. Preparation and characterization of gelatin gel containing indigestible dextrin. Jpn J Hosp Pharm, 22:433–43.
   Google Scholar
• Hanawa T, Nakazawa M, Mohri K, Ito A, Tsuchiya T, Suzuki M, (2000). Development of patient-friendly preparations: Preparation and characterization of allopurinol gelatin gel containing polyethylene oxide. J Pharm Sci Technol., (Jpn), 60:175–82.
   Google Scholar
• Hanawa T, Kasai I, Mohri K, Ito A, Tsuchiya T, Hanawa K, (2000). Development of patient-friendly preparations III; preparation and characterization of carrageenan gel containing polyethylene oxide. Yakugaku Zasshi, 120:1209–16.
   PubMed Web of Science ®Google Scholar
• Endo H, Watanabe Y, Matsumoto M, Shirotake S. (2000). Preparation and evaluation of heat-sensitive melting gel-acetaminophen gel. Jpn J Hosp Pharm, 26:250–8.
   Google Scholar
• Watanabe A, Sugihara M. (1992). New dosage form for the elderly using sodium caseinate treated with moist heat in the form of saturated steam under pressure. Yakuzaigaku, 52:69–78.
   Google Scholar
• Watanabe A, Hanawa T, Sugihara M, Yamamoto K. (1995). Development and pharmaceutical properties of a new oral dosage form of theophylline using sodium caseinate for possible use in elderly patients. Int J Pharm, 117:23–30.
   Google Scholar
• Watanabe A, Hanawa M, Sugihara M. (1994). Application of glycerogelatin as oral dosage form for the elderly. J Pharm Sci Technol., (Jpn), 54:77–87.
   Google Scholar
• Hanawa T, Watanabe A, Tsuchiya T, Ikoma R, Hidaka M, Sugihara M. (1995). New oral dosage form for elderly patients: Preparation and characterization of silk fibroin gel. Chem Pharm Bull, 43:284–8.
   PubMed Web of Science ®Google Scholar
• Hanawa T, Watanabe A, Tsuchiya T, Ikoma R, Hidaka M, Sugihara M. (1995). New oral dosage form for elderly patients. II. Release behaviour of benfotiamine from silk fibroin gel. Chem Pharm Bull, 43:872–6.
   PubMed Web of Science ®Google Scholar
• Hanawa T, Maeda R, Muramatsu E, Suzuki M, Sugihara M, Nakajima M. (2000). New oral dosage form for elderly patients. III. Stability of trichlormethiazide in silk fibroin gel and various sugar solutions. Drug Dev Ind Pharm, 26:1091–97.
   PubMed Web of Science ®Google Scholar
• Kubo W, Miyazaki S, Attwood D. (2003). Oral sustained delivery of paracetamol from in situ-gelling gellan and sodium alginate formulations. Int J Pharm, 258:55–64.
   PubMed Web of Science ®Google Scholar
• Miyazaki S, Aoyama H, Kawasaki N, Kubo W, Attwood D. (1999). In situ gelling gellan formulations as vehicles for oral delivery. J Control Release, 60:287–95.
   PubMed Web of Science ®Google Scholar
• Miyazaki S, Kawasaki N, Kubo W, Endo K, Attwood D. (2001). Comparison of in situ gelling formulations for the oral delivery of cimetidine. Int J Pharm, 220:161–8.
   PubMed Web of Science ®Google Scholar
• Kubo W, Miyazaki S, Dairaku M, Togashi M, Mikami R, Attwood D. (2004). Oral sustained delivery of ambroxol from in situ-gelling pectin formulations. Int J Pharm, 271:233–40.
   PubMed Web of Science ®Google Scholar
• Kubo W, Konno Y, Miyazaki S, Attwood D. (2004). In situ gelling pectin formulations for oral sustained delivery of paracetamol. Drug Dev Ind Pharm, 30:593–9.
   PubMed Web of Science ®Google Scholar
• Kubo W, Itoh K, Miyazaki S, Attwood D. (2005). Oral sustained delivery of theophylline and cimetidine from in situ gelling pectin formulations in rabbits. Drug Dev Ind Pharm, 318:19–25.
   Google Scholar
• Miyazaki S, Kubo W, Itoh K, Konno Y, Fujiwara M, Dairaku M, (2005). The effect of taste masking agents on in situ gelling pectin formulations for oral sustained delivery of paracetamol and ambroxol. Int J Pharm, 297:38–49.
   PubMed Web of Science ®Google Scholar
• Itoh K, Kubo W, Fujiwara M, Hirayama T, Miyazaki S, Dairaku M, (2006). The influence of variation of gastric pH on the gelation and release characteristics of in situ gelling pectin formulations. Int J Pharm, 312:37–42.
   PubMed Web of Science ®Google Scholar
• Itoh K, Kubo W, Fujiwara M, Watanabe H, Miyazaki S, Attwood D. (2006). The influence of gastric acidity and taste masking agent on in situ gelling pectin formulations for oral sustained delivery of acetaminophen. Biol Pharm Bull, 29:343–7.
   PubMed Web of Science ®Google Scholar
• Itoh K, Hirayama T, Takahashi A, Kubo W, Miyazaki S, Dairaku M, (2007). In situ pectin formulations for oral drug delivery at high gastric pH. Int J Pharm, 335:90–6.
   PubMed Web of Science ®Google Scholar
• Kawasaki N, Ohkura R, Miyazaki S, Uno Y, Sugimoto S, Attwood D. (1999). Thermally reversible xyloglucan gels as vehicles for oral drug delivery. Int J Pharm, 181:227–34.
   PubMed Web of Science ®Google Scholar
• Miyazaki S, Kawasaki N, Endo K, Attwood D. (2001). Oral sustained delivery of theophylline from thermally reversible xyloglucan gels in rabbits. J Pharm Pharmacol, 53:1185–91.
   PubMed Web of Science ®Google Scholar
• Miyazaki S, Endo K, Kawasaki N, Kubo W, Watanabe H, Attwood D. (2003). Oral sustained delivery of paracetamol from in situ gelling xyloglucan formulations. Drug Dev Ind Pharm, 29:113–19.
   PubMed Web of Science ®Google Scholar
• Ameer B, Greenblatt DJ, Divoll M, Abernethy DR, Shargel L. (1981). High-performance liquid chromatographic determination of acetaminophen in plasma: Single dose pharmacokinetic studies. J Chromatogr, 226:4–230.
   Google Scholar
• Sugihara M. (1996). Development and application of dosage forms for elderly patients. Pharmaceuticals Monthly, 38:1703–06.
   Google Scholar
• McConnell EL, Basit AW, Murdan S. (2008). Measurement of rat and mouse gastrointestinal pH, fluid and lymphoid tissue, and implications for in-vivo experiments. J Pharm Pharmacol, 60:63–70.
   PubMed Web of Science ®Google Scholar
• Yamaoka K, Tanigawa Y, Nakagawa T, Uno T. (1981). Pharmacokinetic analysis program (MULTI) for microcomputer. J Pharmacobiodyn, 4:879–85.
   PubMedGoogle Scholar
• Dressman JB, Berardi RR, Dermentzoglou LC, Russell TL, Schmaltz SP, Barnett JL, (1990). Upper gastrointestinal pH in young, healthy men and women. Pharm Res, 7:756–61.
   PubMed Web of Science ®Google Scholar